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Abstract: Botulinum toxin type A (BTX-A) injections in masseter muscle can alleviate muscle tightness
and aching pain caused by idiopathic masticatory myalgia, a subform of the myofascial pain syndrome.
Yet the injection procedure (number, amount) is currently empirical. In this ex vivo study, we determined
the feasibility of using contrast-free ultrasound imaging to visualize the short-term injectate propagation.
Ultrasound annotations of BTX-A injectate spread in N = 12 porcine masseter muscles were compared
with the histopathology of the excised masseter. BTX-A presence was automatically detected in the
ultrasound cine by: compensating tissue motion and deformation during injection with a novel spa-
tiotemporal filtering (SF) algorithm, and by imaging tissue swelling strains with strain elastography
(SE). BTX-A injectate introduced 6.5% (standard deviation = 5.0%) echogenicity contrast and 13.9%
(standard deviation = 3.7%) tissue swelling strain. Muscle fasciae were a border for BTX-A distribution.
The SF algorithm achieved significantly higher noise rejection (contrast-to-noise ratio = 4.63) than SE
(2.56, p = 0.01), and state-of-the-art 2-D digital image correlation (1.81, p < 0.001) and direct image
subtraction (1.29, p < 0.001) methods. Histopathology agreed well with ultrasound (Dice coefficient =
0.48), with deviations mainly explained by the three-dimensional inhomogeneous distribution of BTX-A.
Preliminary in vivo patient results indicated that SF and SE discard artifactual BTX-A detection outside
the injection region. The proposed methods contribute to objectivize ultrasound-guided injections, with
additional applications, for instance, to monitor injectate spread of local anesthetics.
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Abstract—Botulinum toxin type A (BTX-A) injections in masseter muscle can alleviate muscle tightness and ach-
ing pain caused by idiopathic masticatory myalgia, a subform of the myofascial pain syndrome. Yet the injection
procedure (number, amount) is currently empirical. In this ex vivo study, we determined the feasibility of using
contrast-free ultrasound imaging to visualize the short-term injectate propagation. Ultrasound annotations of
BTX-A injectate spread in N = 12 porcine masseter muscles were compared with the histopathology of the excised
masseter. BTX-A presence was automatically detected in the ultrasound cine by: compensating tissue motion and
deformation during injection with a novel spatiotemporal filtering (SF) algorithm, and by imaging tissue swelling
strains with strain elastography (SE). BTX-A injectate introduced 6.5% (standard deviation = 5.0%) echogenicity
contrast and 13.9% (standard deviation = 3.7%) tissue swelling strain. Muscle fasciae were a border for BTX-A
distribution. The SF algorithm achieved significantly higher noise rejection (contrast-to-noise ratio = 4.63) than
SE (2.56, p = 0.01), and state-of-the-art 2-D digital image correlation (1.81, p < 0.001) and direct image subtrac-
tion (1.29, p < 0.001) methods. Histopathology agreed well with ultrasound (Dice coefficient = 0.48), with devia-
tions mainly explained by the three-dimensional inhomogeneous distribution of BTX-A. Preliminary in vivo
patient results indicated that SF and SE discard artifactual BTX-A detection outside the injection region. The
proposed methods contribute to objectivize ultrasound-guided injections, with additional applications, for
instance, to monitor injectate spread of local anesthetics. (E-mail: sanse@stanford.edu) © 2020 The Author(s).
Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology. This is an open
access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Key Words: Ultrasound-guided injections, Myofascial pain, Botulinum toxin type A, Motion compensation, Spa-
tiotemporal filtering, Strain elastography, Histopathology.
INTRODUCTION
Masticatory muscle pain is the primary cause for chronic
non-odontogenic orofacial pain, affecting about
12%14% of the adult population, and is related to com-
mon mental states (depression, anxiety, mood and stress-
related disorders) (Wieckiewicz et al. 2017). Clinical
symptoms of idiopathic masticatory myalgia (IMM)
include muscle tightness, aching pain and/or muscular
tenderness (Solberg 1986; Clark 2008; Awan 2017). Botu-
linum toxin type A (BTX-A) is synthesized by the
bacterium Clostridium botulinum and works through
blockade of the release of acetylcholine into the synaptic
cleft and inhibition of the release of neurotransmitters at
sensory nerve endings (Figgit and Noble 2002). Several
randomly allocated placebo-controlled trials have indi-
cated the potential of BTX-A in improving symptoms in
IMM (von Lindern et al. 2003; Guarda-
Nardini et al. 2008; Kurtoglu et al. 2008). Electromyo-
graphically, BTX-A injections resulted in a decrease in
action potential (Kurtoglu et al. 2008). However, the pro-
cedure (number of injections, amount of injectate) is
empirical, and distribution patterns of the substance are
currently unknown (Zhou and Wang 2014). BTX-A injec-
tions are applied in many additional clinical contexts,
such as non-physiologic muscle activity (spasticity,
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tremors, dystonia), neurosecretory dysfunction (sialor-
rhea) and pain conditions, as well as esthetic medicine
(Alter and Karp 2018).
Several guidance approaches have been proposed to
monitor BTX-A injections. Palpation requires no tech-
nology, but cannot distinguish muscle depth or anatomic
variations, and is applicable only for superficial muscles.
Electromyography is useful in identifying muscle targets
and motor points based on their activity, and is useful in
patients with focal dystonia, but it does not provide spa-
tially resolved imaging of muscle and surrounding tissue
structures. Similarly, electrical stimulation (E-Stim) is
applied in upper motor neuron syndromes but is associ-
ated with discomfort to the patient. Imaging techniques
such as fluoroscopy, computed tomography and mag-
netic resonance can help to better identify some muscle
anatomic structures; however, they either require ioniz-
ing radiation or are costly (Alter and Karp 2018).
Ultrasound (US) is a radiation-free, tolerable and
cost-efficient modality, which is widely available for tis-
sue and pathology diagnostics. US-guided injections are
increasingly used to guide musculoskeletal interventions,
allowing for continuous real-time visualization of needle
and target muscles, as well as structures to be protected
(Bruyn and Schmidt 2009; Epis and Bruschi 2014;
Daniels et al. 2018). Clinical outcomes of US-guided
BTX-A injections have been reported, for example, for
sialorrhea (Dogu et al. 2004), muscle spasticity
(Sconfienza et al. 2009) and cervical dystonia
(Hong et al. 2012). US guidance increases safety and
reduces adverse effects. On the other hand, training is
required for sonographic examination, and the outcome
is operator dependent. In general, US-guided injections
typically rely on visualization of the echogenic needle
tip before injection and correct alignment with respect to
target tissue structures. Injectate spread is currently qual-
itatively identified by comparison of multiple frames in
the US cine, where small image contrast variations and
tissue movement and deformation during the injection
process are visually identified (Marhofer et al. 2005;
Bloc et al. 2007; Tran et al. 2009;
McCartney et al. 2010; Andersen et al. 2012). Recently,
contrast-enhanced US (CEUS) has been proposed to
enhance the contrast of the injectate in US images
(Sasaki et al. 2017). However, CEUS complicates the
injection workflow, is off-label, may affect the injection
outcome or may have additional complications for the
patient, all of which need to be carefully verified for
each clinical case.
The goal of this work was to improve the visualiza-
tion of injectate by using conventional US images (B-
mode), without the need for a contrast agent. First, we
acquired a cine of B-mode frames during the injection
process. Next, we used image registration to compensate
for tissue deformation. We exploited the temporal char-
acteristics of the injection process. This allows filtering
out tissue structures from the images and highlighting
small tissue echogenicity and strain variations, which are
caused by the presence of injectate. In the context of this
work, the term deformation compensation is methodo-
logically equivalent to motion compensation, where
motion specifically refers to tissue displacements caused
by physiologic movement, and deformation is a more
generic term that also includes tissue displacements
causes by tissue swelling. US imaging of BTX-A is
finally compared with histopathological assessment of
excised tissue specimens as the reference standard.
METHODS
Experiments
Test patients and injectates. Masseter phantom
with contrast agent. In the setup phase, we examined
injections on fresh loin porcine muscle from the local
slaughterhouse, which was placed in a plastic box and
examined within 12 h after explantation. A 1-mL NaCl
0.9% solution (B. Braun, Bethlehem, PA, USA) was
mixed with US contrast agent (SonoVue 8 ml/mL,
Bracco, Milan, Italy). The masseter phantom was
injected with 1 mL of the compound.
Ex vivo porcine masseter without contrast agent. Six
heads of adult domestic pigs (Sus scrofa domesticus)
(M1M6) with 12 intact masseter muscles (right [R]/left
[L]) were obtained from the local slaughterhouse under
supervision of their veterinary department within 6 h
after butchering. The cutis, subcutis and superficial mus-
cle layers were dissected to reveal the masseter in its
entirety. BTX-A (Xeomin, 150 kD, 50 LD50, Merz
Pharma, Frankfurt am Main, Germany) was diluted in
1 mL NaCl 0.9% (B. Braun). 0.5 mL of BTX-A and
0.5 mL indigo carmine (4 mg/mL, Amino AG, Geben-
storf, Switzerland) were mixed (1:1 ratio). No US con-
trast agent was administered. Eight masseter muscles
(M1M4) were injected with 0.25 mL of the compound,
whereas 0.5 mL was injected in the remaining four
muscles (M5 and M6).
In vivo volunteer. A 40-y-old female patient diagnosed
with IMM was scheduled for BTX-A injection. She had
no prior exposure to this medication. Ultrasound was
approved by the Ethics Committee of the State of Zurich
(KEK-ZH No 2019-01396), and HIPAA-compliant
informed consent was obtained from the patient. The
BTX-A injectate consisted of 1.25 mL NaCl containing
12.5 units of BTX-A. This was slowly infiltrated into the
anterior and posterior portions of each masseter muscle.
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Each injection was aimed at depositing the injectate into
the deepest third of the muscle.
US examination. For phantom and ex vivo experi-
ments, US examinations were performed using a 9 L-D
linear probe (GE Healthcare, Chicago, IL, USA) (band-
width of 2-9 MHz, 192 elements, footprint 44 mm, array
pitch 229 mm) and a GE Logiq E9 US system (Fig. 1).
The probe was fixed in a direction perpendicular to the
muscle fibers using a 3-D-printed transducer holder and
a positioning arm (244 N, Manfrotto, Cassola, Italy).
The holder included a guide tunnel for the syringe on the
side (1 mm diameter), which ensured that the syringe
was placed coplanar to the ultrasound probe with 35˚
inclination and reproducible insertion depth (Fig. 2a).
The needle (25 G£ 1 in., 0.50£ 25 mm BL/LB, Gr 17/
23) was placed on a 25G 1-mL syringe (Primo Luer
Tuberculin 1 mL H82246-1, Codan Medical ApS, Den-
mark). The needle tip was located at 13-mm axial depth,
13-mm lateral position and at half of the transducer ele-
vational plane (5.5 mm) and was tilted 35˚ with respect
to the lateral axis of the transducer. To analyze the vari-
ability of ultrasound images, 10 s of the ultrasound cine
was recorded before injection. Afterward, the BTX-
Aindigo carmine compound was injected (0.25 mL/3
s). The recording was stopped after 60 s. US frame cine
was exported as an offline video in MPG format
(Fig. 2a). The recorded frame rate was 25 frames/s,
resulting in 1500 frames/cine.
For the in vivo injection, a hockey stick probe (GE
L8-18 i-D) intra-operative US transducer (bandwidth
59 MHz, footprint 25 mm) was placed over the thickest
portion of the masseter muscle. The transducer axis was
aligned with the axis of the mandibular body. In this
case, the needle was inserted at a 45˚ angle to the longi-
tudinal axis of the US head so that the needle tip reached
the deep muscle portion in the anterior and posterior
thirds of the muscle. To avoid discomfort for the patient,
the injection was performed immediately (without the
10-s waiting time) after the needle reached the target sta-
ble position. The transducer was attached to the holder
probe during the measurement.
Histopathological assessment. Three-dimensional-
printed frames were adapted to the transducer holder to
ensure the extraction of ex vivo tissue at the measured US
plane. During US data acquisition, the US probe was fitted
into a measurement frame (Fig. 1a, 1b). The frame (6) had
Fig. 1. Experimental setup. (a) Ultrasound measurement (US):
Probe (1) and syringe (2) are positioned coplanar and fixed
with four scalpels (5) to porcine masseter. (b) Computer-aided
design schematic of 3-D-printed probe holder (4) and measure-
ment frame (6). (c) Tissue extraction: The US probe is removed
and a 3-D-printed extraction frame (7) is inserted into (6) to
reproducibly cut out masseter tissue (8) with a scalpel (5). (d)
Computer-aided design schematic of tissue extraction frame.
Fig. 2. Co-registration of ultrasound (US) and histopathology
(HP). (a) US B-mode image. Nominal needle (N) and injection
point (yellow cross) positions are marked, together with
extracted HP region (dashed red rectangle). (b.1) Optic HP
images after successive cryostat cuts (A, B, C) were rendered
into a three-dimensional (3-D) volume (b.2) over the US mea-
surement region. (c) Manual identification of tissue landmarks
(112) in HP (c.1) and US (c.2) images. (c.1) is an average of
the HP volume (b.2) over US slice thickness (elevation). (d)
Registration of HP (d.1) and US image (d.2) and overlaid visu-
alization (d.3). A consistent overlap between US and HP is
observed for muscle fascia (F) and BTX-A injection region (I).
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slits at the edges, where disposable stainless-steel scalpels
(size 22, model 0508, Swann-Morton, Sheffield, UK) were
inserted, allowing fixation to the porcine masseter tissue.
After US measurement, the frame (6) remained attached to
the masseter and the US probe was removed. Then, a sec-
ond 3-D-printed tissue extraction frame (7) was inserted
into the measurement frame (6) (Fig. 1c, 1d). The tissue
extraction frame incorporated additional slits, which
allowed precise cutting and extraction of the masseter tis-
sue (8) at the region of interest. The extracted tissue sample
size was 26 mm (axial)£ 31 mm (lateral)£ 11 mm (eleva-
tional), which fitted exactly into the histopathological
embedding cassette (Macrosette M512, Simport Scientific,
Saint-Mathieu-de-Beloeil, Canada). The tissue sample was
extracted from the tissue surface up to depth of 26 mm; it
was laterally centered with respect to the 44-mm field of
view of the 9 L-D US probe (6.5 mm cropped on each
side) and covered the full US probe elevation range (11
mm). With respect to the extracted tissue sample, the nee-
dle tip was located at 50% axial, 20% lateral and 50% ele-
vation position.
After extraction (<15 min), the masseter tissue was
immediately placed on ice and deep frozen within
60 min (Snapfrost, Excilone, Elancourt, France). The
extracted tissue sample was cut into 20-mm-thick slices
with a Cryostat (Hyrax C60, Carl Zeiss MicroImaging
GmbH, Jena, Germany); 20 slices/sample were extracted
with 500-mm steps along the transducer elevation direc-
tion. For each histopathological slice, optic images were
acquired with a digital camera (PowerShot SX730 HS,
Canon Inc., Tokyo, Japan) (Fig. 2b.1).
Registration of histopathology and ultrasound
images. The 20 acquired histopathological slices
images were co-registered with each other to obtain a 3-
D optic stack (Fig. 2b.2). The plugin “Register Virtual
Stack Slices” (Arganda-Carreras et al. 2006) from FiJi/
ImageJ (1.51 n) was used (Schindelin et al. 2012) (for
further details, see the Appendix). An average image of
the 3-D stack was calculated to obtain a mean optic
representation of the 2-D region of interest measured by
the US probe (Fig. 2c.1). The calculated mean optic
images were registered with their corresponding US
images before the start of the injection process. Common
features in both optic and ultrasonic images were manu-
ally extracted by one examiner (J.K.) using the Control
Point Selection (cpselect) of MATLAB (2016 b, The
MathWorks Inc., Natick, MA, USA). Ten to twenty fea-
ture points were extracted from each image at fascia cor-
ners or branching points (Fig. 2c.2). A projective
transformation was fitted to the control points to align
the optic and US images (Fig. 2d).
Manual annotation of injectate extension. BTX-A
injectate extension was annotated independently by two
examiners (L.R., J.K.) First, each sonographer performed
an annotation of the injectate spread based on visual obser-
vation of only the initial B-mode frame (before injection)
and the last acquired B-mode frame (50 s after injection).
Second, each sonographer performed a second annotation
based on the visual observation of the full recorded US
frame cine. The needle tip position was also annotated
from observation of the US cine. A consensus annotation
was obtained as the commonly annotated pixels by both
readers. Each reader additionally evaluated the level of dif-
ficulty for the video-based and image-based injectate anno-
tations using a Likert score (1 = very easy, 2 = easy,
3 = neutral, 4 = difficult, 5 = very difficult). The BTX-A
injectate extension was annotated in the optical histopathol-
ogy images (before registration with US) by one examiner
(S.J.S). The annotations of US and optic images were per-
formed in a blinded way.
Automatic quantification of injectate spread based on
tissue deformation compensation and spatiotemporal
filtering
US tracking of injectates in muscles reveals charac-
teristic spatiotemporal features, which are utilized as
assumptions to build automatic quantification of injec-
tate spread:
1. The injection process induces local swelling of adja-
cent tissue during the expansion of the injectate,
which is assumed to be characterized by a heteroge-
neous deformation pattern.
2. Musculoskeletal tissue contains hyper-echogenic
muscle fasciae, which are characterized by a higher
echogenicity compared to muscle fascicles and injec-
tate, and thus show strongly dominant contrast fea-
tures in the ultrasound images. Therefore, tissue
deformation compensation is expected to be affected
by strong bias.
3. Correlation between ultrasound frames is reduced
with increasing time separation between compared
frames. One reason for this lies in out-of-plane move-
ments of the hand-held US probe, which significantly
affect the ultrasound echogenicity patterns.
4. Local tissue deformations contain relevant informa-
tion on the injectate presence.
First, we quantify tissue echogenicity changes
caused by injectate presence. Under assumption 1, we
compare deformation compensation based on frame
Direct Subtraction (DS) with frame subtraction after
deformation compensation using a state-of-the-art algo-
rithm (Two-Dimensional Digital Image correlation [2-
D-DIC]) (O’Donnell et al. 1994; Pan et al. 2009). Next,
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we introduce a novel Spatiotemporal Filtering (SF) algo-
rithm, which exploits assumptions 2 and 3. Finally, we
apply Strain Elastography (SE) to visualize injectate-
induced tissue swelling (assumption 4).
Next, the methodological workflow for each of the
algorithms is outlined. Implementation details for each
computational step and examples are provided in the Appen-
dix.
Direct Subtraction. Echogenicity contrast caused
by injectate is visualized by subtracting the acquired B-
mode frames F2; F3; F4; . . . with respect to a reference
frame F1 acquired immediately before the start of the US
injection process F2F1; F3F1; F4F1; . . . (Fig. 3a).
2-D Digital Image Correlation. In a first step
(Fig. 3b.1), the 2-D-DIC algorithm estimates the local
deformation fields u2;1;u3;1; u4;1; . . . between the injec-
tion frames F2; F3; F4; . . . and the reference frame F1. For
this purpose, a deformation tracking processing block
DTij estimates the local deformation fields at each axial i
and lateral j pixel of the image. Deformation tracking is
based on finding the best local match for pixel templates
in the reference and injection frames by maximizing a
correlation function (see calculation details in the
Appendix). At each pixel, the axial u(i, j) and v(i, j) lat-
eral displacement distributions are summarized in a
deformation vector field ub;a ¼ ½uði; jÞ; vði; jÞb;a, where
deformation in frame b is calculated with respect to a ref-
erence frame a.
In a second step (Fig. 3b.2), an interpolation block
Iij uses the calculated deformation fields
u2;1; u3;1; u4;1 . . .to compensate deformation and realign
the acquired B-mode frames F2; F3; F4 . . . with respect to
F1. The interpolation block achieves subpixel accuracy
by performing a gray-scale fit using B-mode values at
neighboring pixels (see Appendix for details). The defor-
mation-corrected frames are written as F2;1; F3;1; F4;1 . . . :
In a third step (Fig. 3b.3), the deformation-corrected
frames F2;1; F3;1; F4;1 . . . : are subtracted with respect to
F1, providing echogenicity contrast F2;1F1; F3;1F1;
F4;1F1; . . . :
Spatiotemporal Filtering. Spatiotemporal Filter-
ing exploits the temporal statistics of the BTX-A injec-
tion process to improve injectate delineation. Both the
deformation calculation and frame subtraction steps in
2-D-DIC (Fig. 3b) are modified to accommodate spatio-
temporal filters. Conceptually, SF splits the deformation
and echogenicity calculation substeps into differential
steps between successive frames. The splitting allows
application of spatial and temporal filters to filter out
Fig. 3. Automatic algorithms for injection spread quantifica-
tion. (a) Direct subtraction (DS) and (b) 2-D Digital Image
Correlation (2-D-DIC) are state-of-the-art algorithms. (c) Spa-
tiotemporal Filtering (SF) (c) and Strain Elastography (SE) are
two proposed solutions, which exploit the dynamics of injec-
tion spread. DS, 2-D-DIC, and SF quantify echogenicity con-
trast, while SE measures tissue swelling strains.
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hyper-echogenic tissue patterns and to highlight the
dynamics of the injection process.
In a first step (Fig. 3c.1), deformation tracking DTij
is calculated between adjacent frame pairs, that is,
between frame F2 and reference frame F1, between
frame F3 and reference frame F2, and so on successively.
This results in differential tissue displacement fields D
u2;1;Du3;2;Du4;3; . . . : At a sufficiently high frame rate
(here 25 frames/s), variations of the imaging scene
between two successive frames, for instance, because of
out-of-plane probe movement, can be neglected. There-
fore, deformation tracking with adjacent frame pairs pro-
vides high-quality tissue displacement estimates for all
frames, characterized by larger correlation maxima. In a
second step (Fig. 3c.2), a high-pass filter HPFn along the
temporal axis n is used to minimize bias patterns while
preserving the injection deformation. This allows filter-
ing out of deformation bias caused by hyper-echogenic
tissue structures. Deformation bias is present as a quasi-
static deformation component in all calculation steps,
whereas physical deformation caused by injection occurs
dynamically with varying patterns in time. In a third step





4;3; . . . ; are then accumulated with
respect to the reference frame F1, resulting in cumulative
displacements u2;1;u3;1;u4;1; . . .. Accumulation of dif-
ferential displacements minimizes correlation loss over
time, which is present in 2-D-DIC, for instance, because
of gradual out-of-plane probe drifts.
In a fourth step (Fig. 3c.4), the interpolation block
Iij is used with the differential tissue displacements
Due2;1;Due3;2;Due4;3; . . . to realign each of the acquired B-
mode frames F2; F3; F4; . . . ; with respect to their preced-
ing frames F1; F2; F3; . . ., resulting in the deformation-
corrected frames F2;1; F3;2; F4;3; . . . : In a fifth step
(Fig. 3c.5), differential echogenicity contrast is calcu-
lated between adjacent frames pairs F2;1F1; F3;2F2;
F4;3F3; . . . : In a sixth step (Fig. 3c.6), the interpola-
tion block Iij is used again to re-align all differential
contrast images F2;1F1; F3;2F2; F4;3F3; . . . ; with
respect to the reference frame F1. For this purpose, the
cumulative displacements u2;1; u3;1; u4;1; . . . ; calculated
in Figure 3c.3 are used. The resulting aligned frames
are written as F2;1F1; F3;1F2;1; F4;1F3;1; . . . : Split-
ting the interpolation into two steps (Fig. 3c.4, 3c.6)
allows using high-quality tissue displacement fields for
differential echogenicity contrast calculation
(Fig. 3c.5), where hyper-echogenic tissue structures are
filtered out.
Next (Fig. 3c.7), a temporal high-pass filter HPFn
along the temporal axis n is applied to the differential
contrast to further minimize the static bias patterns and
to highlight the dynamic injection echogenicity
variations. Additionally (Fig. 3c.8), a spatial median fil-
ter MFij is added to each frame to reduce speckle noise
in the differential contrast images caused by random sub-
pixel uncertainties in the image registration process (var-
iance), together with a thresholding operation to separate
noise from the dynamic injectate component. Finally
(Fig. 3c.9), the filtered differential contrast images ~F 2;1
~F 1; ~F 3;1~F 2;1; ~F 4;1~F 3;1; . . . ; are added to calculate the
cumulative echogenicity contrast with respect to the ref-
erence frame ~F 1. The resulting image cine
~F 2;1~F 1; ~F 3;1~F 1; ~F 4;1~F 1; . . ., provides echogenicity
contrast with respect to the first frame, where SF has
been used to highlight the injectate presence.
Strain Elastography. The calculated deformation
fields u2;1; u3;1; u4;1; . . . ; in Figure 3c.3 are further proc-
essed to quantify tissue swelling strains during the injec-
tion process (Fig. 3d). Each 2-D vector deformation frame
un, 1(i, j), acquired at time instant n, consists of an axial u
(i, j) and a lateral v(i, j) deformation component for each
axial i and lateral j pixel of the image. Axial strain eu ¼ @
u=@i and lateral strain ev ¼ @v=@j are respectively defined
as the derivatives of the displacement fields, and are
added to compute swelling strain e ¼ eu þ ev (Fig. 3d.1).
Strain calculation filters out physiologic tissue movement
and highlights local tissue deformations caused by the
presence of the injectate. While deformation polarity is
accounted for in the image registration (details in Appen-
dix), SE images were visualized in absolute strain values
to highlight the overall extent of the region affected by
the injection.
Implementation details and chosen parameters for
the computation blocks DTij, Iij, HPFn, MF
ij, ɛ are pro-
vided in the Appendix. The same parameters were used
for all experiments (masseter phantom, ex vivo porcine
masseter and in vivo tests). All algorithms and data eval-
uations were implemented in Matlab (2018b, The
MathWorks Inc.).
Quantitative evaluation metrics and statistics
The algorithms DS, 2-D-DIC and SF automatically
quantify injectate echogenicity contrast (%) and SE
swelling strain (%). The temporal median of each video
(US cine) was calculated to summarize the injection pro-
cess into a single frame, which was then compared with
manual US and histopathological annotations. Contrast-
to-noise ratio (CNR) (Varghese and Ophir 1998) was
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where minj; m

bg are the average contrast in the injectate
and the background regions (without injectate), and sbg
is the standard deviation of the contrast in the back-
ground regions. CNR provides a measurement of the
algorithm’s capacity to discriminate injectate from nor-
mal tissue.
The BTX-A region in DS, 2-D-DIC, SE and SF was
segmented with an Otsu threshold (Otsu 1979). BTX-A
presence agreement between US images (manual annota-
tions or automatic quantification) and histopathological
images was evaluated in terms of the Dice coefficient
















inj are the segmented injectate regions for
reference and test images, respectively. The Dice coeffi-
cient ranges from 0 (no overlap between images) to 1
(perfect overlap). Injectate spread surface (mm2) was
also measured from segmentations.
Needle tip position (mm) was automatically seg-
mented by calculating temporal contrast profiles over the
segmented injectate masks. The injection start instant
was tracked by identifying the rise of contrast at 25%
threshold. The needle tip position was estimated as the
centroid of the segmented injectate region, which was
calculated at the injection start instant.
For statistics, median values are provided, together
with 95% confidence intervals (CIs). Performance differ-
ences between metrics were evaluated with a paired sam-
ple t-test. A p value <0.05 was regarded as indicating
statistical significance. To verify the t-test normality
assumption, normal probability plots were qualitatively
assessed for each evaluated metric. Furthermore, a Sha-
piroWilk test of normality was performed (Razali and
Wah 2011).
RESULTS
Masseter phantom with contrast agent
Selected US cine frames during injection, visual-
ized with both B-mode and quantitative algorithms, are
plotted in Figure 4a. The algorithms DS, 2-D-DIC, and
SF quantify injectate echogenicity contrast (%) and SE
swelling strain (%). The NaCl solution with contrast
agent in Figure 4a had high echogenicity contrast with
respect to tissue background (20% of full gray scale),
which allowed direct observation of the injectate (I)
from time t = 10.2 s onward based on single B-mode
frames. Acoustic shadowing artifacts (A) were observed
below the injectate region. Image registration with 2-D-
DIC (CNR = 3.0) revealed only a minor improvement in
injectate (I) delineation and reduction of noise in the
background region with respect to DS (CNR = 2.9). SF
significantly increased CNR (6.6), reducing noise in the
background region while preserving the injectate con-
trast distribution over time. Swelling strains up to 11%
were measured with SE (CNR = 3.4), with spatial corre-
spondence with the BTX-A injectate region. SE artifacts
were observed in the hypo-echogenic region below the
bone (B), where the US signal vanished.
Temporal profiles (Fig. 4b) illustrate the mean val-
ues as a function of time for DS, 2-D-DIC, SF and SE
over annotated injectate (inj) and background (bk)
regions. Temporal profiles (Fig. 4b) over the background
(bk) region (Fig. 4b) exhibit an increase in background
noise from t = 10 s (reference frame) up to§5 s time sep-
aration. Before injection (t = 0 s), DS, 2-D-DIC and SF
revealed respectively 4.6%, 4.0% and 0.23% contrast in
the background region, while SE revealed 1.5% contrast
noise. After injection, noise increased because of the
presence of acoustic shadowing (A). DS, 2-D-DIC, SF
and SE revealed 7.1%, 5.3%, 2.9% and 3.5% contrast in
the background region, respectively.
Ex vivo porcine masseter without contrast agent
The BTX-A injectate without contrast agent in
Figure 5 exhibited low echogenicity contrast (4.4%),
which did not allow visualization based on single B-mode
frames. A continuous play of the US cine was necessary
here to identify the BTX-A region. DS and 2-D-DIC
resolved the injectate region at first injection frames
(t = 13 s), but exhibited poorer delineation with increasing
cine time due to tissue movement and loss of signal coher-
ence. At t = 15 s, DS artifacts (CNR = 0.9) at the hyper-
echogenic bone region (B) were removed by 2-D-DIC,
but at t = 60 s, additional fascia (F) and bone artifacts (B)
could only be partially compensated, and the injection
region was challenging to visualize (CNR = 1.2).
Spatiotemporal Filtering successfully removed
most background tissue artifacts, allowing delineation
of the BTX-A region over time (CNR = 2.5). In this
case, no acoustic shadowing effects are visible. SE
(CNR = 2.6) caused a satisfactory delineation of tissue
swelling strains over the injectate region, with a
minor increase in bk artifacts over time. The injectate
echogenicity contrast profile stabilized in 1.2 s, and
the strain profile flattened after 1 s. This is a shorter
time span than the 3 s in which injectate was continu-
ously applied. Observation of the cine revealed that
the injectate spread area did not grow after 1.2 s,
with additionally injected BTX-A remaining confined
to the same region.
Histopathological assessment of dynamics of BTX-
A infiltration. For all quantitative algorithms (DS, 2-
D-DIC, SF and SE), the temporal median of each
video (US cine) was calculated to summarize the
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injection process into a single frame, which was then
compared with manual US and histopathological
annotations. In Figure 6,visualizations of the histo-
pathological BTX-A spread are projected to the US
coordinate system. The annotated needle tip position
from the US cine images is also visualized. Defining
four quadrants with respect to the needle tip (top left
T-L, top right T-R, bottom left B-L and bottom right
B-R), BTX-A infiltration in multiple quadrants was
simultaneously observed for each sample. BTX-A
infiltration in T-L was observed in 9 of 12 samples,
with 8 of 12 samples for T-R, 6 of 12 samples for B-L
and 2 of 12 samples for B-R. For the 8 of 12 masseter
samples administered 0.25 mL injectate, the BTX-A
infiltration area was 25 mm2 (1543 mm2), while for
the 4 of 12 masseter samples administered 0.5 mL
injectate, the BTX-A infiltration area was 108 mm2
(range: 33222 mm2), with a significant difference in
spread between the two doses (p = 0.013). Longitudi-
nal propagation of BTX-A along muscle fascia was
Fig. 4. Ultrasound-guided injection of NaCl with contrast agent in muscle phantom. (a) Selected injectate snapshots for
B-mode and quantification algorithms of Figure 3 (direct subtraction [DS], 2-D Digital Image Correlation [2-D-DIC]
and Spatiotemporal Filtering [SF]) over a cine recording time of 60 s. The color bars are adjusted to the maximum
observed variations. Needle tip is marked with a yellow cross at t = 0 s. Injection starts at 10.2 s and is marked with a
syringe symbol. At t = 44 s, cine annotation of injectate spread region (inj) is plotted as a red contour. Injectate (I), acous-
tic shadows (A) and artifacts in bone (B) are visible. (b) Time profiles of echogenicity contrast (DS, 2-D-DIC, SF) and
swelling strain (SE) over injection annotation (inj) and background (bk) regions. Injection start is marked with a syringe
symbol. SF reduces background noise with respect to DS, 2-D-DIC and SE, while preserving injectate delineation.
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observed, which seemed to build a border for distribu-
tion, particularly in cases M3-R and M6-L. Further-
more, a backward distribution of BTX-A into the
stitch channel could be seen, when the syringe was
pulled out, particularly in M1-R.
Manual ultrasound annotation. Over the N = 12
measured ex vivo masseter samples, the US readers eval-
uated the effort required for the two-frame annotation
(first and last B-mode frames) with Likert between 2 and
4 and median value 3 (neutral), while cine-based
Fig. 5. Ultrasound-guided injection of BTX-A without contrast agent in ex vivo masseter M2-L. Figure legend is analo-
gous to that of Figure 4, showing both time snapshots (a) and time profiles (b) of echogenicity contrast/strain in the injec-
tate region (inj) with respect to background (bk). Injection occurs at t = 13 s, and injectate spread reaches its end position
around t = 15 s. Because of tissue movement, the direct subtraction (DS) algorithm exhibits artifacts around bone (B)
and fascia (F), which mask the injectate region and grow more severe with increasing cine recording time (t = 60 s). The
proposed strain elastography (SE) and spatiotemporal filtering (SF) algorithms filter out these artifacts, allowing for a
clear delineation of the injectate region (I), with minor differences between t = 15 s and t = 60 s.
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annotation was evaluated with Likert between 1 and 4
and median value 2 (easy).
The Dice coefficient between two reader BTX-A
annotations was 0.64 for two-frame annotation and 0.76
for cine annotation (Fig. 7), with no significant differen-
ces between the two (p = 0.144). Inter-reader error in
BTX-A spread surface estimation was 16.2 mm2
(CI = 821 mm2) for two-frame annotation and 10.7
mm2 (CI = 616 mm2) for cine annotation, with no sig-
nificant difference (p = 0.14). Inter-reader error in needle
tip position based on cine annotation was 0.42 mm (CI:
0.10.7 mm).
Comparison between histopathology and ultra-
sound annotation. Visual comparison (Fig. 6) of US
cine annotations (red solid line) with histopathological
annotations (white solid line) revealed a good spread
delineation agreement for 7 of 12 cases (for instance,
M1-R, M2-L, M3-L, M4-L, M5-R). In 1 of 12 cases (not
shown), there was sliding displacement caused by wrong
scalpel fixation, and tissue was excised outside the US
region of interest. In 4 of 12 cases (for instance, M3-R,
M6-L) BTX-A propagated further to the muscle fibers
on histopathology than on US. Among these 4 of 12
cases, in 2 of 12 cases (for instance, M6-L) the additional
spread not captured by the US probe is associated with
the inhomogeneity of the BTX-A distribution in the
transducer elevation plane (Fig. 8c). For the remaining 2
of 12 cases (for instance M3-R) no elevational inhomo-
geneity of BTX-A distribution is observed (Fig. 8b).
Registration position uncertainty between US and
histopathology based on the method illustrated in
Figure 2c was 1.0 mm. On comparison of US and histo-
pathology BTX-A spread annotations, Dice was 0.43 for
two-frame annotation and 0.48 for full cine annotation,
with no significant differences (p = 0.104). BTX-A
spread surface estimation uncertainty was significantly
larger (p = 0.007) for US two-frame annotation (10.9
mm2, CI = 022 mm2) than for US full cine annotation
(7.6 mm2, CI = 411 mm2). There were no statistically
Fig. 6. Injectate spread in exemplary porcine masseter MX-R/L (X (16): subject index, L = left masseter, R = right
masseter) after 50 s of injection. Ultrasound (US) images (a) before and (b) 50 s after BTX-A injection. (c) For each
injection, the four automatic BTX-A injectate spread quantification algorithms (Fig. 3) are compared. (d) Histopathology
(HP) images co-registered with US images. The consensus US cine annotation is plotted as a red contour in (b)(d). The
HP annotation is plotted as a white contour in (d). Needle tip positions in (d) are marked with a yellow cross. The color
bars are adjusted to the maximum observed variations.
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Fig. 7. (a) Contrast-to-noise ratio (CNR) and (b) Dice coefficient for automatic ultrasound injectate spread quantification
algorithms: Direct Subtraction (DS), 2-D Digital Image Correlation (2-D-DIC), Strain Elastography (SE), and Spatio-
temporal Filtering (SF). CNR and Dice metrics are calculated with respect to both ultrasound cine and histopathology
annotations. The Dice coefficient is also calculated for inter-reader annotation agreement (first/last frame annotation and
annotation of ultrasound cine). On each box, the central line indicates the median, and the bottom and top edges indicate
the 25th and 75th percentiles, respectively. The whiskers extend to the 99% percentiles for normally distributed data;
outliers are plotted with a plus symbol. The notches of the box provide the 95% confidence interval for the median.
Fig. 8. Three-dimensional visualization of botulinum toxin type A (BTX-A) injectate distribution over ultrasound (US)
measurement region. (a) Two-dimensional US probe used in the experiments. Two-dimensional US images are gener-
ated in the axial-lateral plane (a.1). The out-of-plane resolution (a.2) is finite, with a slice thickness of 11 mm limited by
the elevation aperture of the US probe. (b, c) Histopathology (HP) volumes for two masseter samples (M3-R and M6-L
in Fig. 6), where (b.1) and (c.1) illustrate the BTX-A distribution in the axiallateral plane, and (b.2) and (c.2), the
BTX-A distribution along the US probe elevation. M3-R exhibits a constant BTX-A distribution over US slice thickness
(dashed red lines of same length in b.2), which leads to a good agreement between US and HP injectate delineation in
Figure 6. M6-L exhibits a strongly varying BTX-A distribution over US slice thickness (dashed red lines of different
length in (c.2), which leads to an US underestimation of injectate extension with respect to HP in Figure 6.
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significant differences between optic and US area spread
for either two-frame annotation (p = 0.308) or cine anno-
tation (p = 0.245).
Comparison between automatic injectate quantifi-
cation algorithms. In Figure 6, two US injection pro-
cess representations are summarized for seven porcine
masseter muscles: the temporal median of detected echo-
genicity (DS, 2D-DIC, SF) and the temporal median of
strain variations over the 50-s injection process (SE).
Confirming the observations of Figure 5, the SF algo-
rithm exhibited superior noise rejection in background
tissue regions compared with DS and 2-D-DIC, effec-
tively filtering out artifacts at hyper-echogenic tissue
structures (muscle fascia, bone interfaces). Acoustic
shadowing by the BTX-A injectate increased echogenic-
ity in the axial region below the injectate, which was
observed in M3-L, M5-R and M6-L, with a less pro-
nounced effect than in the experiments with contrast
agent in Figure 4. SE effectively measured an increase in
tissue swelling at the annotated injectate region for all
12 of 12 porcine masseter samples. Visually, SE exhib-
ited superior noise rejection compared with DS and 2-D-
DIC. The mean echogenic contrast variation over the
annotation mask after the injection was 6.5%
(SD = 5.0%). The swelling strain was 13.89%
(SD = 3.7%).
Figure 7 illustrates CNR and Dice metrics for DS,
2-D-DIC, SE and SF, including quantiles for each metric
and 95% CIs for the median. With respect to the consensus
US cine annotation, the CNR of SF (4.63) was significantly
higher than that of DS (1.29, p < 0.001), 2-D-DIC (1.81,
p < 0.001) and SE (2.56, p = 0.01), while SE had a signifi-
cantly larger CNR than 2-D-DIC (p < 0.001) and DS (p <
0.001). The Dice coefficient of SF (0.57) was significantly
higher than those of DS (0.21, p = 0.001) and 2-D-DIC
(0.29, p = 0.001), but not significantly different from that of
SE (0.58, p = 0.966), while SE had a significantly higher
Dice coefficient than DS (p < 0.001) and 2-D-DIC
(p = 0.002). The inter-reader Dice coefficient between US
cine annotations was significantly higher than those of SF,
SE, 2-D-DIC and DS (p < 0.001). The inter-reader Dice
coefficient between US two-frame annotations did not sig-
nificantly differ from those of SF (p = 0.064) and SE
(p = 0.085), but was significantly higher than those of 2-D-
DIC (p = 0.002) and SE (p = 0.001). The inter-reader differ-
ences between manual annotation of needle tip position,
compared to automatic needle tip detection, were not signif-
icant for SF (0.89 mm, p = 0.341, CI = 0.31.4 mm), SE
(1.59 mm, p = 0.067, CI = 0.92.3 mm), 2-D-DIC
(1.24 mm, p = 0.095, CI = 0.71.8 mm), and DS (1.18 mm,
p = 0.109, CI = 0.71.7 mm).
With respect to histopathology annotation, the CNR
of SF (2.65) was significantly higher than those of DS
(1.42, p = 0.005), 2-D-DIC (1.76, p = 0.014) and SE (1.91,
p = 0.028), while SE had a significantly larger CNR than
DS (p = 0.002), but a not significantly larger CNR than 2-
D-DIC (p = 0.06) (Fig. 7). With respect to histopathology
annotation, manual US cine annotation revealed signifi-
cantly higher Dice coefficients than automatic annotations
with SF (p = 0.0294), SE (p = 0.002), 2-D-DIC (p = 0.049)
and DS (p = 0.019). Manual US two-frame annotation had
a significantly higher Dice coefficient than SE
Fig. 9. Exemplary in vivo ultrasound-guided BTX-A injection
without contrast agent for a patient diagnosed with idiopathic masti-
catory myalgia (IMM). (a) Selected injectate snapshots. The color
bars are adjusted to the maximum observed variations. (b) Time
profiles of echogenicity contrast and strain. Injection started at
t= 0.5 s, with needle Nmarked in B-mode. At t= 20 s, cine annota-
tion of injectate spread (inj) is plotted as a red contour. Injectate (I)
is successfully delineated by the US quantification algorithms, with
additional artifacts caused by tissue movement (needle N, fascia F,
bone B) and acoustic shadows (A). The 2-D Digital Image Correla-
tion (2-D-DIC), Strain Elastography (SE), and Spatiotemporal Fil-
tering (SF) algorithms reduce bone and fascia artifacts in Direct
Subtraction (DS). Acoustic shadows are alleviated by both SE and
SF. Needle ejection at 6 s leads to a coherent contrast change,
which is captured by SF. Otherwise, SF achieves almost total noise
cancellation in the background (bk) region outside of the injectate.
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(p = 0.0294) and DS (p = 0.043), but did not have a signifi-
cantly different Dice coefficient than automatic annotation
with SF (p = 0.1378) and 2-D-DIC (p = 0.106). No statisti-
cally significant differences in BTX-A spread area were
found between histopathological annotation and SE
(p = 0.2921, ShapiroWilk p = 0.016) or SF (0.6257) seg-
mentations.
All above-evaluated 45 t-test variables qualitatively
approximated straight lines in a normal probability plot
(not shown). Unless explicitly noted, the ShapiroWilk
null hypothesis that the tested variable came from a nor-
mal distribution could not be rejected at a significance
level p = 0.05 for 44 of 45 tests.
In vivo patient
In Figure 9, in vivo time snapshots of the progres-
sion of the BTX-A injectate into the patient’s masseter
are shown for B-mode; DS, 2D-DIC, and SF (echogenic-
ity); and SE (strain swelling). The BTX-A injection
starts at t = 0.5 s and progresses until 5 s, when the BTX-
A spread stabilizes. With respect to the previously dis-
cussed phantom (Fig. 4) and ex vivo cases (Fig.5 and
Fig. 6), there was significant tissue movement during the
injection process. As in previous cases, DS and 2-D-DIC
caused artifacts all over the US image. Both SF and SE
algorithms successfully filtered out these artifacts and
removed false-positive areas outside the annotated mus-
cle injection compartment (marked as “inj” in Fig. 9a).
The injection needle was extracted at t = 6 s, and the
insertion canal (N) could be visualized through the
change in echogenicity contrast. The BTX-A injectate
spread was visible in B-mode and SF as a hypo-echo-
genic fluid region with 10% contrast (I). BTX-A spread
occurred mainly in the right-bottom quadrant with
respect to the needle tip. Tissue swelling strains up to
30% also could be visualized in this region. The readers
consistently annotated a BTX-A injectate region larger
than the one resolved by the automatic algorithms. The
reason was observation of upward displacements in the
fascia F, which were visually associated with BTX-A
diffusion below the fascia F. However, SE did not iden-
tify tissue-swelling strains in this region. An alternative
hypothesis is that the needle movement introduced dis-
placement in the tissue structures.
DISCUSSION
B-mode US successfully visualized BTX-A injec-
tate spread during the first seconds of the injection pro-
cess. Using US contrast agent, injectate visualization by
eye was possible based on single US frames (>20% con-
trast). However, acoustic shadowing artifacts were pres-
ent because of the scattering and attenuation of US
waves with the contrast agents, which complicated the
delineation of injectate extent in the axial direction, in
agreement with (Soetanto and Chan 2000). Without con-
trast agent, BTX-A injectate exhibited smaller contrast
(on average 6.5%). Delineation of spread region was
only possible by observation of two or more frames of
US cine, where differential echogenicity variations and
tissue swelling displacements (on average 13.9%) in
BTX-A spread region allowed estimation of its extent.
This assessment is, however, sonographer dependent,
with measurable differences in annotated spread surfaces
between two readers. Observation of the full cine
improved the consistency of estimation of BTX-A extent
area with respect to histopathology; however, the geo-
metric delineation (Dice coefficient) of the BTX-A
region did not significantly improve, and the annotation
difficulty was more demanding for the readers (Likert
score).
Image processing algorithms, which post-process US
images to quantify tissue echogenicity contrast and tissue
swelling strains caused by injectate spread, can contribute
to facilitate and objectivize injection processes. Blood
flow quantification in human tissues is a state-of-the-art
technology based on Doppler imaging sequences, which
measure the velocity of moving blood particles
(Hoskins et al. 2010). For smaller vessels and lower flow
velocities, such as tumor microvasculature, spatiotempo-
ral image filters have been previously proposed to dis-
criminate tissue movement from angiogenesis (Demene
et al. 2015). Image registration before Doppler imaging
also has been recently applied to decrease the rank of tis-
sue movements and highlight microvasculature
(Nayak et al. 2019). All these methods require custom
ultrafast data acquisition sequences (at 1000 s frames/s) to
track flow. A B-flow modality has also been proposed for
flow imaging based on conventional US imaging sequen-
ces (<100 Hz frames/s) and special source coding, where
image subtraction highlights moving particles with
respect to the stationary background (Weskott 2000). SE
can track tissue displacements as a response to mechanical
excitation, which allows discrimination between stiff and
soft tissues (Shiina et al. 2015). Template matching is reg-
ularly used in SE to measure tissue deformation and strain
(Huang et al. 2019). SE has also been found to detect tem-
perature variations in tissues (Souchon et al. 2005) or
swelling strains associated with the progression of a ther-
mal ablation front (Baki et al. 2015). Automatic visualiza-
tion of injectate spread in soft tissues has so far received
considerably less attention. Image registration with
respect to a reference frame has been reported to improve
the visualization of contrast agents (Gardner et al. 2004;
Dave and Forsberg 2009; Hansen et al. 2016) or to
improve the assessment of tissue echogenicity variations
caused by pathologic processes (Seo et al. 2005). These
works rely on DS or deformation compensation (2-D-
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DIC) of individual frames with respect to a reference
frame.
In this work, we analyzed the temporal dynamics of
the BTX-A injection processes and built up algorithms
that exploit their spatiotemporal characteristics to measure
tissue echogenicity changes (SF) and swelling strains
(SE). The benefits of SF are visually clear in Figures 4, 5,
6 and 9, where no deformation compensation (DS) and
deformation compensation without SF (2-D-DIC) are
compared with SF in different scenarios, including use or
no use of contrast agent, and both ex vivo and in vivo
cases.
With our current setup, BTX-A injectate spread
built up an average surface of 50 mm2 in <3 s, which
corresponds to a flow velocity of <0.15 cm/s. This is
two orders of magnitude below the range of operation of
Doppler systems, which typically display velocities of
tens of centimeters per second (Oglat et al. 2018). On
the other hand, B-mode frame rates (here 25 frames/s)
were enough to acquire multiple observations (2575)
of the injectate spread process. It was observed that DS
imaging of injection spread in muscles was limited by
misalignment of echogenic tissue structures (for
instance, muscle fascia and bone interfaces), which led
to artifactual brightness patterns that masked the visuali-
zation of injectate spread. 2-D-DIC was found to signifi-
cantly reduce these artifacts with respect to DS, yet it is
limited by deformation bias of template matching toward
echogenic patterns. 2-D-DIC also suffers from loss of
tracking coherence and decorrelation with the initial ref-
erence frame with increasing cine time. The effect was
observed in Figure 4 as an increase in background noise
a few seconds after the injection start, and it is probably
owing to out-of-plane tissue displacements during the
injection process, which were not accounted for by the
2-D template matching. SF successfully differentiated
dynamic injectate echogenicity patterns from stationary
tissue deformation bias, and effectively filtered out back-
ground noise, thereby significantly increasing CNR with
respect to DS and 2-D-DIC. By operating on differential
displacements and echogenicity images, decorrelation
with increasing cine time could be avoided. Strain elas-
tography (SE) discriminated injectate presence in terms
of local tissue swelling, with CNR superior to DS and 2-
D-DIC, but CNR inferior to SF. The latter is probably
owing to the double temporal filtering of SF in both tis-
sue displacement and echogenicity domains (Fig. 3c),
while SE only filters out noise in the displacement
domain (Fig. 3d). In terms of injectate region delineation
(Dice coefficient), both SE and SF were superior to 2-D-
DIC and DS, but the differences between SE and SF
were not significant. The disagreement of both SE delin-
eation and SF delineation with respect to consensus two-
frame annotation was not larger than inter-reader
variability. Since inter-reader variability provides a mea-
sure of how accurate a consensus two-frame annotation
could be defined, we can conclude that SE and SF
achieves a similar performance with respect to two-
frame annotation. With respect to histopathology ground
truth, SF was non-inferior to manual two-frame annota-
tion and marginally inferior to cine annotation. No over-
or underestimation bias of histopathological BTX-A
spread surface was found for either SE or SF. Therefore,
both SF and SE shows potential as fast and objective
injectate spread quantification procedures, without need-
ing to sacrifice performance with respect to manual
annotations.
Histopathology exhibited good agreement with US
annotation in 8 of 12 ex vivo masseter cases, with small
positional deviations associated with the sample prepara-
tion process. One limitation was that fascia may change
its direction in the 3-D volume defined by the insonifica-
tion plane and the transducer elevation and, thus, BTX-
A propagation as well. In 2 of 12 cases (Fig. 8c), BTX-A
exhibited an inhomogeneous distribution over the eleva-
tion axis of the transducer, which did not allow consis-
tent monitoring of BTX-A injectate spread based on a 2-
D image. For another 2 of 12 cases (Fig. 8b), a larger
spread of BTX-A was observed in histopathology, which
was not visible in the first seconds monitored by US.
This is probably owing to a later infiltration of the injec-
tate into the muscle fascia during sample extraction
(<15 min) and start of the deep-freezing process (<60
min). Technically, the main limitation of the automatic
algorithms is the limited speckle texture information
available in the B-mode images, which are calculated
after US demodulation and require large correlation tem-
plates (here 2£ 2 mm2) for displacement tracking.
Radiofrequency US data, which contain both phase and
amplitude information, may potentially improve tissue
displacement estimation and provide access to visualiza-
tion of smaller echogenicity contrast variations
(Tavakoli et al. 2010). Real-time three-dimensional
ultrasound imaging may be applied to captured inho-
mogenous three-dimensional injectate spread distribu-
tions.
There is level 1 evidence that instrumented guid-
ance is superior to injections relying on manual guidance
for deeper muscles (Heinen et al. 2006; Alter et al. 2012;
Albanese et al. 2015), where US was highlighted for pre-
cise and painless identification of target muscles with
readily available equipment. Recently, simulation plat-
forms have been developed to train sonographers in
BTX-A muscle injection and infiltration
(Moreno et al. 2019). So far, US guidance has been pri-
marily used to identify the muscle areas that need to be
punctured and to correctly position the injection needle.
For instance, US guidance can avoid mis-injections at
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the salivary gland and prevent inflammation and trauma.
It can also help in deciding the adequate needle length
for each patient to reach the target muscles based on the
thickness of subcutaneous tissue, thereby preventing
BTX-A loss and ensuring more effective therapy (Que-
zada-Gaon et al. 2016).
Speed injection and needle gauge are known factors
that influence uptake of BTX-A (Kinnet 2004). In our
experiments, a large variety of injectate spread surfaces
and directions for the same injectate administration, nee-
dle gauge and injection speed were observed. Muscle
was consistently identified as border structures for BTX-
A distribution, building separate muscle compartments
where BTX-A was confined (Fig. 6). Also, in Figure 4,
the BTX-A spread occurred over the first 1.2 s of injec-
tion, with the additional 1.8 s of administration remain-
ing confined to the same compartment. US guidance
could potentially contribute to ensure a homogeneous
distribution of BTX-A over the target masseter struc-
tures. As fascia connectivity occurs in three dimensions,
direct observation of injectate is necessary to reveal sep-
arate spread compartments in the masseter.
One limitation of our study was the utilization of ex
vivo porcine muscle. While porcine muscle is a suitable
animal model for experimental studies (Tuxen and Kir-
keby 1990), postmortem decomposition and rigor mortis
influence muscle structure. Moreover, no biological
reactions or cardiovascular system is present to process
BTX-A. Further in vivo studies are necessary to investi-
gate the influence of blood flow in drug distribution. The
viscosity of indigo carmine, which was used to dye the
histopathological samples, may also impair the distribu-
tion of BTX-A. The proposed experimental setup is
designed to illustrate that ultrasound imaging offers ade-
quate visualization of the injectate distribution, which is
objectively consistent with histopathology. Preliminary
results revealed that the proposed automatic injectate
segmentation algorithms were applicable to in vivo sce-
narios. Both SF and SE algorithms effectively filtered
out tissue movement (e.g., needle and patient movement)
and artifacts outside the target muscle compartments and
revealed echogenicity contrast variations and swelling
strains in the BTX-A spread regions. For the in vivo case
described (Fig. 9), the two readers consistently identified
a larger BTX-A spread region than the automatic algo-
rithms, based on observed tissue displacements.
However, the tissue displacements outside the BTX-A
region were not associated with tissue swelling in SE
images. A larger population should be studied to parame-
trize and differentiate tissue displacements caused by
BTX-A infiltration from needle and physiologic patient
movement.
Apart from BTX-A infiltration monitoring, the pro-
posed method may be advantageous for other clinical
applications, such as US guidance in regional anesthesia
(Marhofer et al. 2005; McCartney et al. 2010;
Andersen et al. 2012; Sasaki et al. 2017). Visual qualita-
tive US guidance has been applied to monitor spread of
local anesthetic, which allowed real-time identification
of misdistributions of the anesthetic solution and guaran-
teed a faster onset time than the control groups. Also the
anesthetic dose can be injected as close as possible to the
nerve, thus lowering the dose and reducing costs and tox-
icity risks. By minimizing the number of required injec-
tions, potential complications can be reduced, for
instance, pneumothorax or pleural puncture during rip
fractures or breast surgery, where the anesthetic solution
is injected into the paravertebral space
(Marhofer et al. 1998; Willschke et al. 2006;
Santonastaso et al. 2018).
CONCLUSIONS
US B-mode allowed monitoring of BTX-A injectate
spread during the first minute of the injection process, in
agreement with histopathological observations. Spatio-
temporal filtering algorithms and SE can quantify echo-
genic contrast differences and tissue swelling during the
deformation process and provide objectivization with
respect to visual assessment. US allows identification of
bounded BTX-A spread compartments within the muscle
tissue limited by muscle fascia.
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APPENDIX
Co-registration of histopathological images into three-dimensional stack
The plugin “Register Virtual Stack Slices” uses the Scale Invariant Feature Transform (SIFT) (Lowe 2004) for
automatic robust feature identification. Outliers are filtered out using the Random Sample Consensus (RANSAC)
(Fischler and Bolles 1981). The registration of the images is performed with a free affine transformation model for the
full optic image and then fine-tuned with a second registration over the tissue region of interest. Figure 2 b.2 shows a 3-
D render of the BTX-A region of the registered stack, which was generated with ParaView software (Ahrens et al. 2005).
Implementation of algorithm building blocks
US frames were pre-processed to eliminate headers, normalized to a scale 0 to 1, cropped to the HP region of inter-
est, and binned by a factor of 2 to an isotropic pixel size (axial, lateral) of 100 mm x 100 mm (Fig. 2 a).
Deformation tracking DTij between B-mode frames Fa, Fb was performed with two-dimensional zero-normalized
cross-correlation (ZNCC) (Pan et al. 2009) to estimate the axial u(i, j) and v(i, j) lateral displacements fields for each
axial i and lateral j image pixels (Eq A1):






























where Fb and Fa are average values respect the summation ranges. A template matching blockWI£WJ of 20 £ 20 pix-
els (2 mm £ 2 mm), together with a search space S of 10 pixels (1 mm) were used. For 2-D sub-pixel estimation of
deformation fields, a 6-coefficient non-separable two-dimensional parabola was fitted with least squares to the maxi-
mum of the ZNCC function and its 9 neighboring lags [-1, 0, 1], following the method of (Azar et al. 2010).
The interpolation block Iij was implemented with bilinear interpolation, using the 9 neighboring lags [-1, 0, 1] of
each pixel to estimate sub-pixel gray-scale values. The high-pass filter HPFnðF
i;j




n ;NÞ is based on a
one-dimensional median filter MFn along the temporal axis n. The filter order N was 100 (4 s) for differential displace-
ments (HPF1n) and 30 (1.2 s) for differential contrast images (HPF2n). The spatial filter step was implemented with a
two-dimensional median filterMFij of order 3 (0.3 mm), followed by a threshold cut for contrast values <0.02. All final
SE, 2-D-DIC and SF images were presented in the plots in absolute contrast units, and additionally filtered with a two-
dimensional median filter of order 10 (1 mm) to facilitate visualization and automatic segmentation.
Strain fields were calculated with a weighted least-squares estimator based on (Kallel and Ophir 1997) (Eq A2):
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where the window WI£WJ of 20 £ 20 pixels (2 mm £ 2 mm) defines the strain resolution. λk.l is a weighted smooth-
ing kernel, implemented with a two-dimensional Hanning window.
Figure A1 shows an example of the calculation of Strain Elastography (SE) images for ex vivo masseter (M2-L).
B-mode images are provided as a reference (Fig. A1 a). Exemplary tracked axial deformation Du (Fig. A1 b) and tempo-
rally filtered differential displacements ~Du (Fig. A1 c) are shown, corresponding to the outputs of steps Figure 3 c1 and
Figure 3 c2. The temporal filtering step filters out deformation bias at hyperechogenic muscle fascia, which are visible
as quasi-horizontal displacement patterns in Du, thus highlighting the deformation at the injectate region in Figure A1
c. Figure A1 d and A1 e show the cumulative deformation fields corresponding to the output of Figure 3 c3, which are
used as input to the SE calculation process (Fig. 3 d).
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Tissue expansion starts at the needle tip. Therefore,
deformation is in opposite polarity across the needle
location. This can be observed for axial displacement
(Fig. A1 d), where tissue deforms upward toward the
probe (u< 0) above the needle tip, and downward
toward the tissue (u> 0) below the needle tip. Similarly,
for lateral displacement (Fig. A1 e): on the right of the
needle tip, tissue deforms from left most pixel to right
most pixel (v> 0). On the left side of the needle tip, tis-
sue deforms from right most pixel to left most pixel
(v< 0). As outlined in Figure 3 d, tissue swelling ɛ is
calculated by adding up axial gradients of displacement
(ɛu, Fig. A1 f) and lateral gradients of displacement (ɛv,
Fig. A1 g). Tissue shows expansion (ɛ> 0) in the direc-
tion of injectate propagation, accompanied by tissue
compression (ɛ< 0) in adjacent tissues to accommodate
injectate-induced deformation (Fig.A1 h). Since tissue
expansion and compression showed heterogeneous pat-
terns for different samples, it was overall observed that
Figure A1. Detailed steps of Strain Elastography (SE) image
calculation, illustrated exemplarily for ex-vivo masseter M2-L.
a) As a visual reference, B-mode images of the injection pro-
cess and US cine annotation are shown. The needle tip position
is marked with a cross. Differential displacements are shown
before Du (b) and after ~Du (c) temporal filtering, illustrating
deformation bias reduction. d) Cumulative axial deformation u
(i, j) for each axial i and lateral j pixel of the image. e) Cumula-
tive lateral deformation v(i, j). d) Axial strain eu ¼ @u=@i. e)
Lateral strain ev ¼ @v=@j. f) Swelling strain e ¼ eu þ ev. Tissue
expansion (ɛ< 0) is observed in injectate region, accompanied
by compression (ɛ< 0) of adjacent tissues. i) SE images are
plotted in absolute strain values |ɛ|.
Figure A2. Detailed steps of Spatiotemporal Filtering (SF)
image calculation, illustrated exemplarily for ex-vivo masseter
M2-L. a) As a visual reference, B-mode images of the injection
process and US cine annotation are shown. b) Intermediate SF
images with none of the filters in Fig. 3c, that is, HPF1n,
HPF2n and MF
ij, activated. c) Intermediate SF images with
only the temporal filter HPF1n activated. d) Intermediate SF
images as in c) with temporal filter HPF2n additionally acti-
vated. e) Intermediate SF imagesas in d) with spatial MFij
thresholding operation additionally activated. f) Final SF image
as in e) with spatialMFij median filter additionally activated.
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using absolute strains |ɛ| (Fig. A1 i) was adequate to
evaluate the extent of injectate presence.
Figure A2 exemplifies the calculation of echogenic-
ity contrast images with Spatiotemporal Filtering (SF)
for M2-L, thereby highlighting the impact of the filters
in the final images. B-mode images are provided as a ref-
erence (Fig. A2 a). Figure A2 b shows the SF calcula-
tion, when the temporal filtering of the differential
displacements (HPF1n, Fig. 3 c.2) is suppressed. Due to
the accumulation of bias deformation components in
each differential step, the resulting SF image shows
reduced contrast between background and injectate.
Figure A2 c shows the SF image with HPF1n active but
we no further filtering of echogenicity frames. The injec-
tate region is successfully revealed. Figure A2 d shows
the SF image after temporal filtering HPF2n in Figure 3
c.7, noise outside the injectate region is further reduced.
The contribution is small in this example, since the probe
setup is fixed and no physiologic movement is present.
Figure A2 e shows the SF image after thresholding the
differential echogenicity frames in Figure 3 c.8 before
accumulation. The threshold filter separates noise and
dynamic injectate components in the gray-scale histo-
gram, contributing to the delineation of the injection
region. Figure A2 f shows the additional noise reduction
effect of the spatial median filter MFij in Figure 3.c8,
providing the final SF image.
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